Goldman Sachs’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-794,380
Closed -$1.61M 7493
2016
Q1
$1.61M Buy
794,380
+544,729
+218% +$972K ﹤0.01% 3672
2015
Q4
$619K Sell
249,651
-173,850
-41% -$516K ﹤0.01% 4733
2015
Q3
$1.1M Buy
423,501
+18,135
+4% +$47.3K ﹤0.01% 4380
2015
Q2
$1.27M Sell
405,366
-471,188
-54% -$1.61M ﹤0.01% 4303
2015
Q1
$2.51M Sell
876,554
-189,904
-18% -$485K ﹤0.01% 3560
2014
Q4
$2.75M Buy
1,066,458
+1,042,344
+4,323% +$4.56M ﹤0.01% 3535
2014
Q3
$180K Sell
24,114
-958
-4% -$8.95K ﹤0.01% 6241
2014
Q2
$295K Sell
25,072
-183,636
-88% -$1.96M ﹤0.01% 5855
2014
Q1
$2.42M Buy
208,708
+190,161
+1,025% +$2.24M ﹤0.01% 3794
2013
Q4
$202K Sell
18,547
-326,758
-95% -$3.22M ﹤0.01% 5958
2013
Q3
$3.72M Buy
345,305
+229,518
+198% +$2.61M ﹤0.01% 3262
2013
Q2
$1.36M Buy
+115,787
New +$1.16M ﹤0.01% 4117

Goldman Sachs's SZYM Position: Q2 2016 in Review

Goldman Sachs sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 794,380 shares — an estimated $1.61M sold.

Goldman Sachs first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $3.72M in Q3 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Goldman Sachs reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Goldman Sachs sold 794,380 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $1.61M.
  • Goldman Sachs first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Goldman Sachs's SOLAZYME INC COM STK (DE) position peaked at $3.72M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.